Stem cell factor consistently improves thymopoiesis after experimental transplantation of murine or human hematopoietic stem cells in immunodeficient mice

Journal of Immunology

Volumn 187, Issue 6, 2011, Pages 2974-2981

  Wils, Evert Jan ^a   Rombouts, Elwin J C ^a   Van Mourik, Irene ^a   Spits, Hergen ^b   Legrand, Nicolas ^b   Braakman, Eric ^a   Cornelissen, Jan J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LYMPH NODE; LYMPHOID PROGENITOR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; THYMOCYTE; THYMOPOIESIS DEFICIENCY; THYMUS DISEASE;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL SEPARATION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOPOIESIS; MICE; MICE, INBRED C57BL; STEM CELL FACTOR; T-LYMPHOCYTES; THYMUS GLAND;

EID: 80053071817     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1004209     Document Type: Article

References (60)

1. Wils, E. J., and J. J. Cornelissen. 2005. Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement. Blood Rev. 19: 89-98.
2. Williams, K. M., and R. E. Gress. 2008. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation. Best Pract. Res. Clin. Haematol. 21: 579-596.
3. Storek, J., M. Geddes, F. Khan, B. Huard, C. Helg, Y. Chalandon, J. Passweg, and E. Roosnek. 2008. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin. Immunopathol. 30: 425-437.
4. Rufer, N., C. Helg, B. Chapuis, and E. Roosnek. 2001. Human memory T cells: lessons from stem cell transplantation. Trends Immunol. 22: 136-141. (Pubitemid 32675260)
5. Hakim, F. T., and R. E. Gress. 2002. Reconstitution of thymic function after stem cell transplantation in humans. Curr. Opin. Hematol. 9: 490-496. (Pubitemid 35191117)
6. Douek, D. C., R. A. Vescio, M. R. Betts, J. M. Brenchley, B. J. Hill, L. Zhang, J. R. Berenson, R. H. Collins, and R. A. Koup. 2000. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355: 1875-1881. (Pubitemid 30311880)
7. Weinberg, K., B. R. Blazar, J. E. Wagner, E. Agura, B. J. Hill, M. Smogorzewska, R. A. Koup, M. R. Betts, R. H. Collins, and D. C. Douek. 2001. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97: 1458-1466. (Pubitemid 32183773)
8. Chung, B., L. Barbara-Burnham, L. Barsky, and K. Weinberg. 2001. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood 98: 1601-1606.
9. Hakim, F. T., S. A. Memon, R. Cepeda, E. C. Jones, C. K. Chow, C. Kasten- Sportes, J. Odom, B. A. Vance, B. L. Christensen, C. L. Mackall, and R. E. Gress. 2005. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J. Clin. Invest. 115: 930-939. (Pubitemid 40489397)
10. Krenger, W., and G. A. Holländer. 2008. The thymus in GVHD pathophysiology. Best Pract. Res. Clin. Haematol. 21: 119-128. (Pubitemid 351712710)
11. Clave, E., M. Busson, C. Douay, R. Peffault de Latour, J. Berrou, C. Rabian, M. Carmagnat, V. Rocha, D. Charron, G. Socié, and A. Toubert. 2009. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood 113: 6477-6484.
12. Van den Brink, M. R., O. Alpdogan, and R. L. Boyd. 2004. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat. Rev. Immunol. 4: 856-867. (Pubitemid 39490761)
13. Chidgey, A. P., N. Seach, J. Dudakov, M. V. Hammett, and R. L. Boyd. 2008. Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches. Semin. Immunopathol. 30: 457-477.
14. Seggewiss, R., and H. Einsele. 2010. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 115: 3861-3868.
15. Fry, T. J., M. Sinha, M. Milliron, Y. W. Chu, V. Kapoor, R. E. Gress, E. Thomas, and C. L. Mackall. 2004. Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution. Blood 104: 2794-2800. (Pubitemid 39434964)
16. Wils, E. J., E. Braakman, G. M. Verjans, E. J. Rombouts, A. E. Broers, H. G. Niesters, G. Wagemaker, F. J. Staal, B. Löwenberg, H. Spits, and J. J. Cornelissen. 2007. Flt3 ligand expands lymphoid progenitors prior to recovery of thymopoiesis and accelerates T cell reconstitution after bone marrow transplantation. J. Immunol. 178: 3551-3557. (Pubitemid 46417621)
17. Godfrey, D. I., A. Zlotnik, and T. Suda. 1992. Phenotypic and functional characterization of c-Kit expression during intrathymic T cell development. J. Immunol. 149: 2281-2285.
18. Galy, A. H., R. De Waal Malefyt, A. Barcena, S. M. Peterson, and H. Spits. 1993. Untransfected and SV40-transfected fetal and postnatal human thymic stromal cells. Analysis of phenotype, cytokine gene expression and cytokine production. Thymus 22: 13-33. (Pubitemid 23355047)
19. Rodewald, H. R., K. Kretzschmar, W. Swat, and S. Takeda. 1995. Intrathymically expressed c-Kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity 3: 313-319.
20. Rodewald, H. R., M. Ogawa, C. Haller, C. Waskow, and J. P. DiSanto. 1997. Prothymocyte expansion by c-Kit and the common cytokine receptor gamma chain is essential for repertoire formation. Immunity 6: 265-272. (Pubitemid 27148593)
21. Massa, S., G. Balciunaite, R. Ceredig, and A. G. Rolink. 2006. Critical role for c-Kit (CD117) in T cell lineage commitment and early thymocyte development in vitro. Eur. J. Immunol. 36: 526-532.
22. Fewkes, N. M., A. C. Krauss, M. Guimond, J. L. Meadors, S. Dobre, and C. L. Mackall. 2010. Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment after hematopoietic stem cell transplantation. Blood 115: 4120-4129.
23. Patchen, M. L., R. Fischer, E. A. Schmauder-Chock, and D. E. Williams. 1994. Mast cell growth factor enhances multilineage hematopoietic recovery in vivo following radiation-induced aplasia. Exp. Hematol. 22: 31-39. (Pubitemid 24111995)
24. Chung, B., D. Min, L. W. Joo, M. R. Krampf, J. Huang, Y. Yang, S. Shashidhar, J. Brown, E. P. Dudl, and K. I. Weinberg. 2011. Combined effects of interleukin- 7 and stem cell factor administration on lymphopoiesis after murine bone marrow transplantation. Biol. Blood Marrow Transplant. 17: 48-60.
25. -/- mice. Methods Mol. Biol. 595: 87-115.
26. -/- mice without affecting peripheral T cell homeostasis. J. Immunol. 183: 7645-7655.
27. Balciunaite, G., R. Ceredig, S. Massa, and A. G. Rolink. 2005. A B220+ CD117+ CD19- hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur. J. Immunol. 35: 2019-2030. (Pubitemid 41015041)
28. Bhandoola, A., H. Von Boehmer, H. T. Petrie, and J. C. Zúñiga-Pflücker. 2007. Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity 26: 678-689. (Pubitemid 46907669)
29. Douek, D. C., R. D. McFarland, P. H. Keiser, E. A. Gage, J. M. Massey, B. F. Haynes, M. A. Polis, A. T. Haase, M. B. Feinberg, J. L. Sullivan, et al. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695. (Pubitemid 29003949)
30. Poulin, J. F., M. N. Viswanathan, J. M. Harris, K. V. Komanduri, E. Wieder, N. Ringuette, M. Jenkins, J. M. McCune, and R. P. Sékaly. 1999. Direct evidence for thymic function in adult humans. J. Exp. Med. 190: 479-486. (Pubitemid 29395376)
31. Storek, J., A. Joseph, M. A. Dawson, D. C. Douek, B. Storer, and D. G. Maloney. 2002. Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Transplantation 73: 1154-1158. (Pubitemid 34415453)
32. Lewin, S. R., G. Heller, L. Zhang, E. Rodrigues, E. Skulsky, M. R. Van den Brink, T. N. Small, N. A. Kernan, R. J. O'Reilly, D. D. Ho, and J. W. Young.2002. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood 100: 2235-2242. (Pubitemid 35001261)
33. Bolotin, E., M. Smogorzewska, S. Smith, M. Widmer, and K. Weinberg. 1996. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88: 1887-1894. (Pubitemid 26307089)
34. Mackall, C. L., T. J. Fry, C. Bare, P. Morgan, A. Galbraith, and R. E. Gress. 2001. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97: 1491-1497. (Pubitemid 32183777)
35. Alpdogan, O., S. J. Muriglan, J. M. Eng, L. M. Willis, A. S. Greenberg, B. J. Kappel, and M. R. Van den Brink. 2003. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J. Clin. Invest. 112: 1095-1107. (Pubitemid 38056324)
36. Storek, J., T. Gillespy, III, H. Lu, A. Joseph, M. A. Dawson, M. Gough, J. Morris, R. C. Hackman, P. A. Horn, G. E. Sale, et al. 2003. Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys. Blood 101: 4209-4218. (Pubitemid 36857906)
37. Broers, A. E., S. J. Posthumus-van Sluijs, H. Spits, B. Van der Holt, B. Löwenberg, E. Braakman, and J. J. Cornelissen. 2003. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants. Blood 102: 1534-1540. (Pubitemid 36988068)
38. Chi, A. W., J. J. Bell, D. A. Zlotoff, and A. Bhandoola. 2009. Untangling the T branch of the hematopoiesis tree. Curr. Opin. Immunol. 21: 121-126.
39. Schwarz, B. A., A. Sambandam, I. Maillard, B. C. Harman, P. E. Love, and A. Bhandoola. 2007. Selective thymus settling regulated by cytokine and chemokine receptors. J. Immunol. 178: 2008-2017. (Pubitemid 46233397)
40. Serwold, T., L. I. Ehrlich, and I. L. Weissman. 2009. Reductive isolation from bone marrow and blood implicates common lymphoid progenitors as the major source of thymopoiesis. Blood 113: 807-815.
41. Saran, N., M. Lyszkiewicz, J. Pommerencke, K. Witzlau, R. Vakilzadeh, M. Ballmaier, H. Von Boehmer, and A. Krueger. 2010. Multiple extrathymic precursors contribute to T-cell development with different kinetics. Blood 115: 1137-1144.
42. Waskow, C., S. Paul, C. Haller, M. Gassmann, and H. R. Rodewald. 2002. Viable c-Kit(W/W) mutants reveal pivotal role for c-Kit in the maintenance of lymphopoiesis. Immunity 17: 277-288. (Pubitemid 35279549)
43. Karsunky, H., M. Merad, A. Cozzio, I. L.Weissman, and M. G. Manz. 2003. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J. Exp. Med. 198: 305-313. (Pubitemid 36987855)
44. Mestas, J., and C. C. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172: 2731-2738. (Pubitemid 38263654)
45. Majeti, R., C. Y. Park, and I. L. Weissman. 2007. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1: 635-645. (Pubitemid 350215330)
46. Manz, M. G., T. Miyamoto, K. Akashi, and I. L. Weissman. 2002. Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl. Acad. Sci. USA 99: 11872-11877. (Pubitemid 34994491)
47. Galy, A., M. Travis, D. Cen, and B. Chen. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3: 459-473.
48. Haddad, R., F. Guimiot, E. Six, F. Jourquin, N. Setterblad, E. Kahn, M. Yagello, C. Schiffer, I. Andre-Schmutz, M. Cavazzana-Calvo, et al. 2006. Dynamics of thymus-colonizing cells during human development. Immunity 24: 217-230. (Pubitemid 43214590)
49. Blom, B., and H. Spits. 2006. Development of human lymphoid cells. Annu. Rev. Immunol. 24: 287-320.
50. Six, E. M., D. Bonhomme, M. Monteiro, K. Beldjord, M. Jurkowska, C. Cordier- Garcia, A. Garrigue, L. Dal Cortivo, B. Rocha, A. Fischer, et al. 2007. A human postnatal lymphoid progenitor capable of circulating and seeding the thymus. J. Exp. Med. 204: 3085-3093.
51. DeCastro, C. M., S. M. Denning, S. Langdon, G. R. Vandenbark, J. Kurtzberg, R. Scearce, B. F. Haynes, and R. E. Kaufman. 1994. The c-Kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes. Exp. Hematol. 22: 1025-1033. (Pubitemid 24292896)
52. Ktorza, S., S. Sarun, F. Rieux-Laucat, J. P. De Villartay, P. Debré, and C. Schmitt. 1995. CD34-positive early human thymocytes: T cell receptor and cytokine receptor gene expression. Eur. J. Immunol. 25: 2471-2478.
53. Kawashima, I., E. D. Zanjani, G. Almaida-Porada, A. W. Flake, H. Zeng, and M. Ogawa. 1996. CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood 87: 4136-4142. (Pubitemid 26152257)
54. Borge, O. J., V. Ramsfjell, L. Cui, and S. E. Jacobsen. 1997. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood 90: 2282-2292. (Pubitemid 27392712)
55. Sitnicka, E., N. Buza-Vidas, S. Larsson, J. M. Nygren, K. Liuba, and S. E. Jacobsen. 2003. Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-Kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood 102: 881-886. (Pubitemid 36917779)
56. Legrand, N., K. Weijer, and H. Spits. 2006. Experimental models to study development and function of the human immune system in vivo. J. Immunol. 176: 2053-2058. (Pubitemid 43201649)
57. Manz, M. G. 2007. Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 26: 537-541. (Pubitemid 46756351)
58. Awong, G., E. Herer, C. D. Surh, J. E. Dick, R. N. La Motte-Mohs, and J. C. Zúñiga-Pflücker. 2009. Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. Blood 114: 972-982.
59. Huntington, N. D., N. Legrand, N. L. Alves, B. Jaron, K. Weijer, A. Plet, E. Corcuff, E. Mortier, Y. Jacques, H. Spits, and J. P. Di Santo. 2009. IL-15 transpresentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 206: 25-34.
60. Legrand, N., A. Ploss, R. Balling, P. D. Becker, C. Borsotti, N. Brezillon, J. Debarry, Y. De Jong, H. Deng, J. P. Di Santo, et al. 2009. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 6: 5-9.